Breaking News Instant updates and real-time market news.

PANW

Palo Alto Networks

$373.69 /

+6.645 (+1.81%)

16:09
08/23/21
08/23
16:09
08/23/21
16:09

Palo Alto Networks authorizes additional $676.1M for share repurchase

Subsequent to quarter end, the board of directors authorized an additional $676.M for share repurchase, increasing the remaining authorization for future share repurchases to $1B, expiring December 31, 2022.

  • 23

    Aug

  • 13

    Sep

  • 13

    Sep

PANW Palo Alto Networks
$373.69 /

+6.645 (+1.81%)

08/06/21 OTR Global
Palo Alto Networks view downgraded to Mixed from Positive at OTR Global
07/26/21
Fly Intel: Top five analyst downgrades
07/26/21 Loop Capital
Palo Alto Networks downgraded to Hold from Buy at Loop Capital
07/26/21 Loop Capital
Palo Alto Networks downgraded to Hold from Buy at Loop Capital

TODAY'S FREE FLY STORIES

Upgrade
Standard Chartered upgraded to Equal Weight from Underweight at Barclays » 05:08
09/17/21
09/17
05:08
09/17/21
05:08
SCBFY

Standard Chartered

$12.16 /

-0.025 (-0.21%)

Barclays analyst Aman…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SCBFY Standard Chartered
$12.16 /

-0.025 (-0.21%)

09/15/21 Exane BNP Paribas
Standard Chartered upgraded to Neutral from Underperform at Exane BNP Paribas
08/11/21 Morgan Stanley
Standard Chartered price target raised to 480 GBp at Morgan Stanley
08/10/21 UBS
Standard Chartered price target lowered to 465 GBp from 490 GBp at UBS
07/07/21 UBS
Standard Chartered price target lowered to 490 GBp from 530 GBp at UBS
Upgrade
HSBC upgraded to Overweight from Underweight at Barclays » 05:07
09/17/21
09/17
05:07
09/17/21
05:07
HSBC

HSBC

$25.49 /

-0.25 (-0.97%)

Barclays analyst Aman…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HSBC HSBC
$25.49 /

-0.25 (-0.97%)

HSBC HSBC
$25.49 /

-0.25 (-0.97%)

05:01 Today RBC Capital
HSBC upgraded to Outperform from Sector Perform at RBC Capital
08/09/21 RBC Capital
HSBC price target lowered to 450 GBp from 480 GBp at RBC Capital
08/05/21 Morgan Stanley
HSBC price target raised to 450 GBp from 430 GBp at Morgan Stanley
08/04/21 JPMorgan
HSBC upgraded to Overweight from Neutral at JPMorgan
HSBC HSBC
$25.49 /

-0.25 (-0.97%)

HSBC HSBC
$25.49 /

-0.25 (-0.97%)

HSBC HSBC
$25.49 /

-0.25 (-0.97%)

Hot Stocks
Fresenius Medical enters home dialysis distribution deal in Japan with JMS Co. » 05:06
09/17/21
09/17
05:06
09/17/21
05:06
FMS

Fresenius Medical

$35.31 /

-0.36 (-1.01%)

Fresenius Medical Care…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FMS Fresenius Medical
$35.31 /

-0.36 (-1.01%)

FMS Fresenius Medical
$35.31 /

-0.36 (-1.01%)

09/10/21 Barclays
Fresenius Medical downgraded to Equal Weight from Overweight at Barclays
09/10/21 JPMorgan
Fresenius Medical downgraded to Underweight from Neutral at JPMorgan
08/11/21 JPMorgan
Fresenius Medical price target raised to EUR 61.30 from EUR 58.80 at JPMorgan
08/04/21 Societe Generale
Fresenius Medical price target raised to EUR 71 from EUR 64 at Societe Generale
FMS Fresenius Medical
$35.31 /

-0.36 (-1.01%)

General news
FX Update: USD-JPY has lifted to a three-day high » 05:05
09/17/21
09/17
05:05
09/17/21
05:05
$ECON

Economic Data

/

+

FX Update: USD-JPY has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

Downgrade
Novatek downgraded to Hold from Buy at HSBC » 05:04
09/17/21
09/17
05:04
09/17/21
05:04
NOVKY

Novatek

$260.36 /

-7.9048 (-2.95%)

HSBC analyst Ildar…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NOVKY Novatek
$260.36 /

-7.9048 (-2.95%)

06/03/21 VTB Capital
Novatek upgraded to Buy from Hold at VTB Capital
01/15/21 JPMorgan
Novatek downgraded to Neutral from Overweight at JPMorgan
12/16/20 Renaissance Capital
Novatek downgraded to Hold from Buy at Renaissance Capital
11/27/20 VTB Capital
Novatek downgraded to Hold from Buy at VTB Capital
Upgrade
HSBC upgraded to Outperform from Sector Perform at RBC Capital » 05:01
09/17/21
09/17
05:01
09/17/21
05:01
HSBC

HSBC

$25.49 /

-0.25 (-0.97%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HSBC HSBC
$25.49 /

-0.25 (-0.97%)

HSBC HSBC
$25.49 /

-0.25 (-0.97%)

08/09/21 RBC Capital
HSBC price target lowered to 450 GBp from 480 GBp at RBC Capital
08/05/21 Morgan Stanley
HSBC price target raised to 450 GBp from 430 GBp at Morgan Stanley
08/04/21 JPMorgan
HSBC upgraded to Overweight from Neutral at JPMorgan
08/03/21 DBS Bank
HSBC upgraded to Buy from Hold at DBS Bank
HSBC HSBC
$25.49 /

-0.25 (-0.97%)

HSBC HSBC
$25.49 /

-0.25 (-0.97%)

HSBC HSBC
$25.49 /

-0.25 (-0.97%)

Initiation
Kingspan initiated with an Outperform at Credit Suisse » 04:57
09/17/21
09/17
04:57
09/17/21
04:57
KGSPY

Kingspan

$114.12 /

-1.158 (-1.00%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KGSPY Kingspan
$114.12 /

-1.158 (-1.00%)

09/07/21 Berenberg
Kingspan price target raised to EUR 110 from EUR 100 at Berenberg
08/26/21 Deutsche Bank
Kingspan price target raised to EUR 94 from EUR 85 at Deutsche Bank
08/23/21 Barclays
Kingspan price target raised to EUR 85 from EUR 75 at Barclays
08/23/21 JPMorgan
Kingspan price target raised to EUR 83 from EUR 76 at JPMorgan
Downgrade
Take-Two downgraded to Market Perform from Outperform at BMO Capital » 04:55
09/17/21
09/17
04:55
09/17/21
04:55
TTWO

Take-Two

$151.89 /

-0.78 (-0.51%)

BMO Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TTWO Take-Two
$151.89 /

-0.78 (-0.51%)

TTWO Take-Two
$151.89 /

-0.78 (-0.51%)

09/14/21 Ascendiant
Take-Two price target lowered to $198 from $216 at Ascendiant
09/13/21 JPMorgan
Activision should be bought on China regulation concerns, says JPMorgan
09/10/21 Truist
Apple will likely appeal ruling in Epic case, says Truist
09/10/21 Baird
Apple ruling could be positive for mobile game publishers, says Baird
TTWO Take-Two
$151.89 /

-0.78 (-0.51%)

TTWO Take-Two
$151.89 /

-0.78 (-0.51%)

TTWO Take-Two
$151.89 /

-0.78 (-0.51%)

TTWO Take-Two
$151.89 /

-0.78 (-0.51%)

Conference/Events
Leap Therapeutics to host conference call » 04:55
09/17/21
09/17
04:55
09/17/21
04:55
LPTX

Leap Therapeutics

$2.52 /

+0.57 (+29.23%)

Conference call to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LPTX Leap Therapeutics
$2.52 /

+0.57 (+29.23%)

LPTX Leap Therapeutics
$2.52 /

+0.57 (+29.23%)

09/16/21 Piper Sandler
Leap data show 'very favorable early signal,' says Piper Sandler
09/13/21 Raymond James
Leap Therapeutics price target raised to $4 from $3 at Raymond James
09/13/21 Piper Sandler
Leap combo sees 'strong' early response rate, says Piper Sandler
06/03/21 Baird
Leap Therapeutics transferred with Outperform at Baird
LPTX Leap Therapeutics
$2.52 /

+0.57 (+29.23%)

LPTX Leap Therapeutics
$2.52 /

+0.57 (+29.23%)

Conference/Events
ChannelAdvisor to hold virtual analyst day » 04:55
09/17/21
09/17
04:55
09/17/21
04:55
ECOM

ChannelAdvisor

$26.97 /

-0.12 (-0.44%)

Virtual Analyst Day to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ECOM ChannelAdvisor
$26.97 /

-0.12 (-0.44%)

ECOM ChannelAdvisor
$26.97 /

-0.12 (-0.44%)

02/12/21 B. Riley Securities
ChannelAdvisor price target raised to $36 from $30 at B. Riley Securities
02/09/21 B. Riley Securities
ChannelAdvisor price target raised to $30 from $24.50 at B. Riley Securities
11/05/20 Baird
ChannelAdvisor price target lowered to $18 from $20 at Baird
10/16/20
Fly Intel: Top five analyst upgrades
ECOM ChannelAdvisor
$26.97 /

-0.12 (-0.44%)

Conference/Events
Truist to hold a virtual bus tour » 04:55
09/17/21
09/17
04:55
09/17/21
04:55
ATVI

Activision Blizzard

$79.31 /

+1.06 (+1.35%)

, EA

Electronic Arts

$135.85 /

-1.21 (-0.88%)

, MGNI

Magnite

$29.48 /

-0.52 (-1.73%)

, PLTK

Playtika

$28.51 /

+0.15 (+0.53%)

, RBLX

Roblox

$81.40 /

-0.725 (-0.88%)

, ROKU

Roku

$323.03 /

+4.41 (+1.38%)

, VZIO

Vizio

$18.33 /

-0.4 (-2.14%)

, ZNGA

Zynga

$7.99 /

-0.045 (-0.56%)

Digital…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ATVI Activision Blizzard
$79.31 /

+1.06 (+1.35%)

EA Electronic Arts
$135.85 /

-1.21 (-0.88%)

MGNI Magnite
$29.48 /

-0.52 (-1.73%)

PLTK Playtika
$28.51 /

+0.15 (+0.53%)

RBLX Roblox
$81.40 /

-0.725 (-0.88%)

ROKU Roku
$323.03 /

+4.41 (+1.38%)

VZIO Vizio
$18.33 /

-0.4 (-2.14%)

ZNGA Zynga
$7.99 /

-0.045 (-0.56%)

ATVI Activision Blizzard
$79.31 /

+1.06 (+1.35%)

09/15/21 KeyBanc
EA's delay of Battlefield 2042 slight positive for Activision, says KeyBanc
09/15/21 Benchmark
EA shares reacting negatively to Battlefield 2042 delay rumors, says Benchmark
09/15/21 Truist
Battlefield 2042 delay would be 'modest negative' for EA, says Truist
09/13/21 JPMorgan
Activision should be bought on China regulation concerns, says JPMorgan
EA Electronic Arts
$135.85 /

-1.21 (-0.88%)

09/15/21 KeyBanc
EA's delay of Battlefield 2042 slight positive for Activision, says KeyBanc
09/15/21 Benchmark
EA shares reacting negatively to Battlefield 2042 delay rumors, says Benchmark
09/15/21 Raymond James
Delay of EA's Battlefield 2042 likely a 'mild negative,' says Raymond James
09/15/21 Truist
Battlefield 2042 delay would be 'modest negative' for EA, says Truist
MGNI Magnite
$29.48 /

-0.52 (-1.73%)

09/16/21 Susquehanna
Magnite upbeat analyst reaffirms positive thesis, says Susquehanna
08/31/21 Macquarie
Macquarie starts 'SSP leader' Magnite at Outperform
08/31/21 Macquarie
Magnite initiated with an Outperform at Macquarie
08/09/21 RBC Capital
Magnite assumed with an Outperform at RBC Capital
PLTK Playtika
$28.51 /

+0.15 (+0.53%)

09/10/21 Wedbush
Wedbush says Apple injunction could boost earnings for mobile game makers
09/10/21 Baird
Apple ruling could be positive for mobile game publishers, says Baird
08/05/21 Cowen
Playtika valuation remains extremely attractive, says Cowen
06/30/21 Morgan Stanley
Morgan Stanley double downgrades overvalued AppLovin to Underweight
RBLX Roblox
$81.40 /

-0.725 (-0.88%)

09/15/21 Benchmark
Benchmark reiterates Sell rating on Roblox after 'weak' August indicators
09/15/21 Truist
Roblox key performance indicators for August 'solid,' says Truist
09/10/21 Truist
Apple will likely appeal ruling in Epic case, says Truist
08/31/21 Jefferies
China crackdown 'more serious' for Roblox than U.S. publishers, says Jefferies
ROKU Roku
$323.03 /

+4.41 (+1.38%)

09/13/21 Stephens
Recent Apple TV+ news positive for Roku, says Stephens
09/09/21 Stephens
Premium prices of Amazon TVs reduces risk for Roku, says Stephens
09/09/21 KeyBanc
New Amazon Fire TVs 'incremental positive' for Roku, says KeyBanc
09/09/21 JPMorgan
Vizio added as new best idea in SMID-cap U.S. Internet at JPMorgan
VZIO Vizio
$18.33 /

-0.4 (-2.14%)

09/14/21
Fly Intel: Top five analyst initiations
09/14/21 Stephens
Stephens starts Vizio at Overweight with $27 price target
09/13/21 Stephens
Vizio initiated with an Overweight at Stephens
09/13/21 Stephens
Recent Apple TV+ news positive for Roku, says Stephens
ZNGA Zynga
$7.99 /

-0.045 (-0.56%)

09/10/21 Truist
Apple will likely appeal ruling in Epic case, says Truist
09/10/21 Wedbush
Wedbush says Apple injunction could boost earnings for mobile game makers
09/10/21 Baird
Apple ruling could be positive for mobile game publishers, says Baird
08/31/21 Jefferies
China crackdown 'more serious' for Roblox than U.S. publishers, says Jefferies
ATVI Activision Blizzard
$79.31 /

+1.06 (+1.35%)

EA Electronic Arts
$135.85 /

-1.21 (-0.88%)

MGNI Magnite
$29.48 /

-0.52 (-1.73%)

PLTK Playtika
$28.51 /

+0.15 (+0.53%)

RBLX Roblox
$81.40 /

-0.725 (-0.88%)

ROKU Roku
$323.03 /

+4.41 (+1.38%)

VZIO Vizio
$18.33 /

-0.4 (-2.14%)

ZNGA Zynga
$7.99 /

-0.045 (-0.56%)

  • 25
    Mar
  • 15
    Jan
ATVI Activision Blizzard
$79.31 /

+1.06 (+1.35%)

EA Electronic Arts
$135.85 /

-1.21 (-0.88%)

RBLX Roblox
$81.40 /

-0.725 (-0.88%)

ROKU Roku
$323.03 /

+4.41 (+1.38%)

ZNGA Zynga
$7.99 /

-0.045 (-0.56%)

ATVI Activision Blizzard
$79.31 /

+1.06 (+1.35%)

EA Electronic Arts
$135.85 /

-1.21 (-0.88%)

MGNI Magnite
$29.48 /

-0.52 (-1.73%)

PLTK Playtika
$28.51 /

+0.15 (+0.53%)

RBLX Roblox
$81.40 /

-0.725 (-0.88%)

ROKU Roku
$323.03 /

+4.41 (+1.38%)

VZIO Vizio
$18.33 /

-0.4 (-2.14%)

ZNGA Zynga
$7.99 /

-0.045 (-0.56%)

ATVI Activision Blizzard
$79.31 /

+1.06 (+1.35%)

EA Electronic Arts
$135.85 /

-1.21 (-0.88%)

MGNI Magnite
$29.48 /

-0.52 (-1.73%)

RBLX Roblox
$81.40 /

-0.725 (-0.88%)

ROKU Roku
$323.03 /

+4.41 (+1.38%)

VZIO Vizio
$18.33 /

-0.4 (-2.14%)

ZNGA Zynga
$7.99 /

-0.045 (-0.56%)

Conference/Events
PJT Partners participates in a conference call with JMP Securities » 04:55
09/17/21
09/17
04:55
09/17/21
04:55
PJT

PJT Partners

$76.77 /

-0.46 (-0.60%)

Conference call with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PJT PJT Partners
$76.77 /

-0.46 (-0.60%)

PJT PJT Partners
$76.77 /

-0.46 (-0.60%)

04/08/21 Wolfe Research
PJT Partners downgraded to Peer Perform from Outperform at Wolfe Research
03/25/21 Keefe Bruyette
PJT Partners initiated with an Outperform at Keefe Bruyette
12/16/20 Seaport Global
Seaport Global starts PJT Partners at Buy with $91 price target
12/16/20 Seaport Global
PJT Partners initiated with a Buy at Seaport Global
PJT PJT Partners
$76.77 /

-0.46 (-0.60%)

Conference/Events
Baidu participates in a conference call with Mizuho » 04:55
09/17/21
09/17
04:55
09/17/21
04:55
BIDU

Baidu

$159.54 /

-2.12 (-1.31%)

Conference call with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BIDU Baidu
$159.54 /

-2.12 (-1.31%)

BIDU Baidu
$159.54 /

-2.12 (-1.31%)

09/06/21 KGI Securities
Baidu initiated with a Neutral at KGI Securities
08/20/21
Fly Intel: Top five analyst downgrades
08/20/21 Erste Group
Baidu downgraded to Sell from Hold at Erste Group
08/18/21 Susquehanna
Baidu price target lowered to $200 from $250 at Susquehanna
BIDU Baidu
$159.54 /

-2.12 (-1.31%)

  • 26
    Mar
BIDU Baidu
$159.54 /

-2.12 (-1.31%)

BIDU Baidu
$159.54 /

-2.12 (-1.31%)

BIDU Baidu
$159.54 /

-2.12 (-1.31%)

Conference/Events
Ambarella management to meet with MKM Partners » 04:55
09/17/21
09/17
04:55
09/17/21
04:55
AMBA

Ambarella

$152.64 /

+0.05 (+0.03%)

Meeting to be held on…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMBA Ambarella
$152.64 /

+0.05 (+0.03%)

AMBA Ambarella
$152.64 /

+0.05 (+0.03%)

09/02/21 Roth Capital
Ambarella price target raised to $170 from $130 at Roth Capital
09/01/21 Cowen
Ambarella price target raised to $150 from $140 at Cowen
09/01/21 Craig-Hallum
Ambarella price target raised to $170 from $150 at Craig-Hallum
09/01/21 Wells Fargo
Ambarella price target raised to $115 from $110 at Wells Fargo
AMBA Ambarella
$152.64 /

+0.05 (+0.03%)

AMBA Ambarella
$152.64 /

+0.05 (+0.03%)

AMBA Ambarella
$152.64 /

+0.05 (+0.03%)

Conference/Events
MarketWise management to meet virtually with Oppenheimer » 04:55
09/17/21
09/17
04:55
09/17/21
04:55
MKTW

MarketWise

$9.00 /

+0.33 (+3.81%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MKTW MarketWise
$9.00 /

+0.33 (+3.81%)

MKTW MarketWise
$9.00 /

+0.33 (+3.81%)

08/31/21 UBS
UBS starts MarketWise with a Buy
08/31/21 UBS
MarketWise initiated with a Buy at UBS
08/19/21 Wedbush
Wedbush bullish on MarketWise, initiates with an Outperform
08/19/21 Wedbush
MarketWise initiated with an Outperform at Wedbush
Conference/Events
TCR2 Therapeutics to host conference call » 04:55
09/17/21
09/17
04:55
09/17/21
04:55
TCRR

TCR2 Therapeutics

$15.71 /

-0.51 (-3.14%)

Management provides an…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TCRR TCR2 Therapeutics
$15.71 /

-0.51 (-3.14%)

TCRR TCR2 Therapeutics
$15.71 /

-0.51 (-3.14%)

08/06/21 BMO Capital
TCR2 Therapeutics price target lowered to $44 from $53 at BMO Capital
06/24/21 Goldman Sachs
TCR2 Therapeutics initiated with a Buy at Goldman Sachs
06/11/21 BMO Capital
TCR2 Therapeutics coverage transferred at BMO Capital
05/14/21 Wedbush
TCR2 Therapeutics price target lowered to $45 from $57 at Wedbush
TCRR TCR2 Therapeutics
$15.71 /

-0.51 (-3.14%)

  • 20
    Jan
Conference/Events
Molina Healthcare to hold a virtual investor day » 04:55
09/17/21
09/17
04:55
09/17/21
04:55
MOH

Molina Healthcare

$270.03 /

+3.94 (+1.48%)

Virtual Investor Day to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MOH Molina Healthcare
$270.03 /

+3.94 (+1.48%)

MOH Molina Healthcare
$270.03 /

+3.94 (+1.48%)

09/09/21 Cowen
Molina Healthcare initiated with an Outperform at Cowen
09/08/21 Mizuho
Selloff in managed care sector overdone, says Mizuho
07/30/21 BMO Capital
Molina Healthcare price target raised to $315 from $300 at BMO Capital
07/30/21 Mizuho
Molina Healthcare price target raised to $284 from $273 at Mizuho
MOH Molina Healthcare
$270.03 /

+3.94 (+1.48%)

MOH Molina Healthcare
$270.03 /

+3.94 (+1.48%)

Conference/Events
Citigroup to hold a virtual conference » 04:55
09/17/21
09/17
04:55
09/17/21
04:55

Small/Mid-Cap &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
BofA to hold a virtual conference » 04:55
09/17/21
09/17
04:55
09/17/21
04:55
RHHBY

Roche

$46.82 /

-0.04 (-0.09%)

, ALLO

Allogene Therapeutics

$24.53 /

-0.42 (-1.68%)

, ATR

AptarGroup

$122.29 /

-2.415 (-1.94%)

, FMS

Fresenius Medical

$35.31 /

-0.36 (-1.01%)

, SNY

Sanofi

$48.20 /

+0.185 (+0.39%)

, WAT

Waters

$399.60 /

-10.23 (-2.50%)

, ALNY

Alnylam

$190.23 /

+2.63 (+1.40%)

, BLUE

Bluebird Bio

$17.67 /

-0.12 (-0.67%)

, AZN

AstraZeneca

$56.60 /

+0.14 (+0.25%)

, EXEL

Exelixis

$20.53 /

+0.04 (+0.20%)

, FOLD

Amicus

$11.09 /

-0.06 (-0.54%)

, PFE

Pfizer

$44.46 /

-0.31 (-0.69%)

, PAHC

Phibro Animal Health

$21.32 /

-0.08 (-0.37%)

, QGEN

Qiagen

$54.15 /

+0.6601 (+1.23%)

, IONS

Ionis Pharmaceuticals

$36.45 /

-0.55 (-1.49%)

Global Healthcare Virtual…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RHHBY Roche
$46.82 /

-0.04 (-0.09%)

ALLO Allogene Therapeutics
$24.53 /

-0.42 (-1.68%)

ATR AptarGroup
$122.29 /

-2.415 (-1.94%)

FMS Fresenius Medical
$35.31 /

-0.36 (-1.01%)

SNY Sanofi
$48.20 /

+0.185 (+0.39%)

WAT Waters
$399.60 /

-10.23 (-2.50%)

ALNY Alnylam
$190.23 /

+2.63 (+1.40%)

BLUE Bluebird Bio
$17.67 /

-0.12 (-0.67%)

AZN AstraZeneca
$56.60 /

+0.14 (+0.25%)

EXEL Exelixis
$20.53 /

+0.04 (+0.20%)

FOLD Amicus
$11.09 /

-0.06 (-0.54%)

PFE Pfizer
$44.46 /

-0.31 (-0.69%)

QGEN Qiagen
$54.15 /

+0.6601 (+1.23%)

IONS Ionis Pharmaceuticals
$36.45 /

-0.55 (-1.49%)

RHHBY Roche
$46.82 /

-0.04 (-0.09%)

09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
09/07/21 UBS
Roche price target raised to CHF 350 from CHF 345 at UBS
08/02/21 JPMorgan
Roche price target raised to CHF 360 from CHF 310 at JPMorgan
07/27/21 Societe Generale
Roche price target raised to CHF 353 from CHF 340 at Societe Generale
ALLO Allogene Therapeutics
$24.53 /

-0.42 (-1.68%)

08/06/21 B. Riley
Allogene Therapeutics price target lowered to $40 from $52 at B. Riley
08/05/21 Oppenheimer
Allogene Therapeutics price target lowered to $44 from $52 at Oppenheimer
08/05/21 Oppenheimer
Allogene Therapeutics price target lowered to $44 from $52 at Oppenheimer
06/21/21 Jefferies
Allogene Therapeutics assumed with a Buy at Jefferies
ATR AptarGroup
$122.29 /

-2.415 (-1.94%)

09/13/21 Baird
AptarGroup price target lowered to $135 from $150 at Baird
08/02/21 William Blair
William Blair downgrades AptarGroup after 'underwhelming quarter'
08/02/21 William Blair
AptarGroup downgraded to Market Perform from Outperform at William Blair
04/19/21 Deutsche Bank
AptarGroup price target raised to $162 from $152 at Deutsche Bank
FMS Fresenius Medical
$35.31 /

-0.36 (-1.01%)

09/10/21 Barclays
Fresenius Medical downgraded to Equal Weight from Overweight at Barclays
09/10/21 JPMorgan
Fresenius Medical downgraded to Underweight from Neutral at JPMorgan
08/11/21 JPMorgan
Fresenius Medical price target raised to EUR 61.30 from EUR 58.80 at JPMorgan
08/04/21 Societe Generale
Fresenius Medical price target raised to EUR 71 from EUR 64 at Societe Generale
SNY Sanofi
$48.20 /

+0.185 (+0.39%)

09/14/21 Mizuho
Kadmon downgraded to Neutral from Buy at Mizuho
09/10/21 UBS
Kadmon downgraded to Neutral from Buy at UBS
09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
09/09/21 Benchmark
Sanofi deal for Kadmon reinforces Incyte thesis, says Benchmark
WAT Waters
$399.60 /

-10.23 (-2.50%)

08/04/21 SVB Leerink
Waters price target raised to $385 from $370 at SVB Leerink
08/04/21 Baird
Waters price target raised to $360 from $297 at Baird
08/04/21 Citi
Waters price target raised to $400 from $315 at Citi
07/06/21 Evercore ISI
Evercore ISI upgrades Waters to Outperform on turnaround progress
ALNY Alnylam
$190.23 /

+2.63 (+1.40%)

08/27/21 BMO Capital
Alnylam price target raised to $196 from $174 at BMO Capital
08/04/21 Barclays
Alnylam price target raised to $216 from $196 at Barclays
08/04/21 Piper Sandler
Alnylam downgraded to Neutral from Overweight at Piper Sandler
06/30/21 Piper Sandler
Alnylam's zilebesiran has 'best in class' potential, says Piper Sandler
BLUE Bluebird Bio
$17.67 /

-0.12 (-0.67%)

08/10/21
Fly Intel: Top five analyst downgrades
08/10/21 BMO Capital
Bluebird Bio price target lowered to $21 from $29 at BMO Capital
08/10/21 Canaccord
Bluebird Bio downgraded to Hold from Buy at Canaccord
08/10/21 Mizuho
Bluebird Bio price target lowered to $29 from $70 at Mizuho
AZN AstraZeneca
$56.60 /

+0.14 (+0.25%)

09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
08/12/21 JPMorgan
AstraZeneca resumed with an Overweight at JPMorgan
08/11/21 Goldman Sachs
FibroGen price target lowered to $16 from $22 at Goldman Sachs
08/09/21 Morgan Stanley
AstraZeneca resumed with an Overweight at Morgan Stanley
EXEL Exelixis
$20.53 /

+0.04 (+0.20%)

08/06/21 H.C. Wainwright
Exelixis price target raised to $64 from $35 at H.C. Wainwright
06/29/21 H.C. Wainwright
Exelixis price target lowered to $35 from $47 at H.C. Wainwright
06/29/21 Oppenheimer
Exelixis price target lowered to $27 from $35 at Oppenheimer
06/28/21 Piper Sandler
Exelixis selloff on trial miss an overreaction, says Piper Sandler
FOLD Amicus
$11.09 /

-0.06 (-0.54%)

07/19/21 BTIG
Amicus assumed with a Buy at BTIG
07/09/21 Chardan
Amicus coverage transferred at Chardan
07/01/21 Berenberg
Amicus assumed with a Hold at Berenberg
05/27/21 Needham
Amicus initiated with a Hold at Needham
PFE Pfizer
$44.46 /

-0.31 (-0.69%)

09/16/21 Canaccord
Exact Sciences salesforce expansion a net positive, says Canaccord
09/16/21 BofA
Moderna boosters already reflected in 'bullish' consensus, says BofA
09/15/21 Raymond James
Exact Sciences' 'opportunistic' hires should boost sales, says Raymond James
09/13/21 JPMorgan
Pfizer price target raised to $42 from $40 at JPMorgan
PAHC Phibro Animal Health
$21.32 /

-0.08 (-0.37%)

08/04/21 Credit Suisse
Phibro Animal Health assumed with a Neutral at Credit Suisse
07/07/21
Fly Intel: Top five analyst downgrades
07/07/21 Barclays
Phibro Animal Health downgraded to Underweight from Equal Weight at Barclays
QGEN Qiagen
$54.15 /

+0.6601 (+1.23%)

07/14/21 Citi
Qiagen price target lowered to $58 from $65 at Citi
07/14/21 Kepler Cheuvreux
Qiagen downgraded to Hold from Buy at Kepler Cheuvreux
06/11/21 Berenberg
Qiagen price target lowered to EUR 54 from EUR 56 at Berenberg
06/03/21 Goldman Sachs
Qiagen initiated with a Neutral at Goldman Sachs
IONS Ionis Pharmaceuticals
$36.45 /

-0.55 (-1.49%)

07/15/21 Canaccord
Bicycle Therapeutics price target raised to $40 from $36 at Canaccord
07/14/21 Benchmark
Bicycle deal 'makes little sense' for Ionis, says Benchmark
07/13/21 William Blair
Bicycle collaboration a positive for Ionis, says William Blair
07/13/21 Piper Sandler
Bicycle Therapeutics price target raised to $46 from $39 at Piper Sandler
RHHBY Roche
$46.82 /

-0.04 (-0.09%)

ALLO Allogene Therapeutics
$24.53 /

-0.42 (-1.68%)

ATR AptarGroup
$122.29 /

-2.415 (-1.94%)

SNY Sanofi
$48.20 /

+0.185 (+0.39%)

WAT Waters
$399.60 /

-10.23 (-2.50%)

ALNY Alnylam
$190.23 /

+2.63 (+1.40%)

BLUE Bluebird Bio
$17.67 /

-0.12 (-0.67%)

AZN AstraZeneca
$56.60 /

+0.14 (+0.25%)

EXEL Exelixis
$20.53 /

+0.04 (+0.20%)

FOLD Amicus
$11.09 /

-0.06 (-0.54%)

PFE Pfizer
$44.46 /

-0.31 (-0.69%)

PAHC Phibro Animal Health
$21.32 /

-0.08 (-0.37%)

QGEN Qiagen
$54.15 /

+0.6601 (+1.23%)

IONS Ionis Pharmaceuticals
$36.45 /

-0.55 (-1.49%)

RHHBY Roche
$46.82 /

-0.04 (-0.09%)

SNY Sanofi
$48.20 /

+0.185 (+0.39%)

AZN AstraZeneca
$56.60 /

+0.14 (+0.25%)

PFE Pfizer
$44.46 /

-0.31 (-0.69%)

RHHBY Roche
$46.82 /

-0.04 (-0.09%)

ALLO Allogene Therapeutics
$24.53 /

-0.42 (-1.68%)

FMS Fresenius Medical
$35.31 /

-0.36 (-1.01%)

SNY Sanofi
$48.20 /

+0.185 (+0.39%)

ALNY Alnylam
$190.23 /

+2.63 (+1.40%)

BLUE Bluebird Bio
$17.67 /

-0.12 (-0.67%)

AZN AstraZeneca
$56.60 /

+0.14 (+0.25%)

EXEL Exelixis
$20.53 /

+0.04 (+0.20%)

FOLD Amicus
$11.09 /

-0.06 (-0.54%)

PFE Pfizer
$44.46 /

-0.31 (-0.69%)

QGEN Qiagen
$54.15 /

+0.6601 (+1.23%)

IONS Ionis Pharmaceuticals
$36.45 /

-0.55 (-1.49%)

AZN AstraZeneca
$56.60 /

+0.14 (+0.25%)

PFE Pfizer
$44.46 /

-0.31 (-0.69%)

IONS Ionis Pharmaceuticals
$36.45 /

-0.55 (-1.49%)

Conference/Events
FDA Pediatric Advisory Committee to hold a meeting » 04:55
09/17/21
09/17
04:55
09/17/21
04:55

The Committee discusses…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
Verona Pharma participates in a conference call with Truist » 04:55
09/17/21
09/17
04:55
09/17/21
04:55
VRNA

Verona Pharma

$5.52 /

+ (+0.00%)

Conference call with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VRNA Verona Pharma
$5.52 /

+ (+0.00%)

VRNA Verona Pharma
$5.52 /

+ (+0.00%)

09/13/21
Fly Intel: Top five analyst initiations
09/13/21 H.C. Wainwright
Verona Pharma initiated with a Buy at H.C. Wainwright
Conference/Events
CBRE Acquisition Holdings management to meet virtually with Roth Capital » 04:55
09/17/21
09/17
04:55
09/17/21
04:55
CBAH

CBRE Acquisition Holdings

$9.94 /

+0.015 (+0.15%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CBAH CBRE Acquisition Holdings
$9.94 /

+0.015 (+0.15%)

CBAH CBRE Acquisition Holdings
$9.94 /

+0.015 (+0.15%)

Conference/Events
European Society for Medical Oncology to hold a virtual meeting » 04:55
09/17/21
09/17
04:55
09/17/21
04:55
ABBV

AbbVie

$108.08 /

+0.29 (+0.27%)

, AYLA

Ayala Pharmaceuticals

$12.26 /

-1.76 (-12.55%)

, DCPH

Deciphera

$31.77 /

+0.72 (+2.32%)

, GMAB

Genmab

$42.26 /

-0.575 (-1.34%)

, LPTX

Leap Therapeutics

$2.52 /

+0.57 (+29.23%)

, ORIC

Oric Pharmaceuticals

$24.49 /

-0.31 (-1.25%)

, SYNH

Syneos Health

$93.78 /

+0.07 (+0.07%)

, BGNE

BeiGene

$385.26 /

+10.94 (+2.92%)

, BMY

Bristol-Myers

$61.22 /

-0.78 (-1.26%)

, BYSI

BeyondSpring

$22.50 /

-0.48 (-2.09%)

, CALA

Calithera Biosciences

$2.05 /

-0.04 (-1.91%)

, GILD

Gilead

$71.32 /

-0.45 (-0.63%)

, GH

Guardant Health

$127.00 /

-0.01 (-0.01%)

, LLY

Eli Lilly

$230.95 /

-2.72 (-1.16%)

, IPSEY

Ipsen

$24.32 /

+0.23 (+0.95%)

, EXAS

Exact Sciences

$102.81 /

-1.83 (-1.75%)

, IDYA

Ideaya Biosciences

$25.90 /

-0.1 (-0.38%)

, GSK

GlaxoSmithKline

$39.10 /

-0.11 (-0.28%)

, RHHBY

Roche

$46.82 /

-0.04 (-0.09%)

, REGN

Regeneron

$652.73 /

+2.13 (+0.33%)

, PFE

Pfizer

$44.46 /

-0.31 (-0.69%)

, TAK

Takeda Pharmaceutical

$17.21 /

+0.205 (+1.21%)

, TMO

Thermo Fisher

$560.75 /

-2.085 (-0.37%)

, TCRR

TCR2 Therapeutics

$15.71 /

-0.51 (-3.14%)

, VERU

Veru

$8.76 /

-0.04 (-0.45%)

, VBLT

VBL Therapeutics

$2.35 /

+0.055 (+2.40%)

, VTRS

Viatris

$13.70 /

-0.03 (-0.22%)

, NVS

Novartis

$84.37 /

-0.695 (-0.82%)

ESMO 2021 Virtual…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ABBV AbbVie
$108.08 /

+0.29 (+0.27%)

AYLA Ayala Pharmaceuticals
$12.26 /

-1.76 (-12.55%)

DCPH Deciphera
$31.77 /

+0.72 (+2.32%)

GMAB Genmab
$42.26 /

-0.575 (-1.34%)

LPTX Leap Therapeutics
$2.52 /

+0.57 (+29.23%)

ORIC Oric Pharmaceuticals
$24.49 /

-0.31 (-1.25%)

SYNH Syneos Health
$93.78 /

+0.07 (+0.07%)

BGNE BeiGene
$385.26 /

+10.94 (+2.92%)

BMY Bristol-Myers
$61.22 /

-0.78 (-1.26%)

BYSI BeyondSpring
$22.50 /

-0.48 (-2.09%)

CALA Calithera Biosciences
$2.05 /

-0.04 (-1.91%)

GILD Gilead
$71.32 /

-0.45 (-0.63%)

GH Guardant Health
$127.00 /

-0.01 (-0.01%)

LLY Eli Lilly
$230.95 /

-2.72 (-1.16%)

IPSEY Ipsen
$24.32 /

+0.23 (+0.95%)

EXAS Exact Sciences
$102.81 /

-1.83 (-1.75%)

IDYA Ideaya Biosciences
$25.90 /

-0.1 (-0.38%)

GSK GlaxoSmithKline
$39.10 /

-0.11 (-0.28%)

RHHBY Roche
$46.82 /

-0.04 (-0.09%)

REGN Regeneron
$652.73 /

+2.13 (+0.33%)

PFE Pfizer
$44.46 /

-0.31 (-0.69%)

TAK Takeda Pharmaceutical
$17.21 /

+0.205 (+1.21%)

TMO Thermo Fisher
$560.75 /

-2.085 (-0.37%)

TCRR TCR2 Therapeutics
$15.71 /

-0.51 (-3.14%)

VERU Veru
$8.76 /

-0.04 (-0.45%)

VBLT VBL Therapeutics
$2.35 /

+0.055 (+2.40%)

VTRS Viatris
$13.70 /

-0.03 (-0.22%)

NVS Novartis
$84.37 /

-0.695 (-0.82%)

ABBV AbbVie
$108.08 /

+0.29 (+0.27%)

09/14/21 Barclays
Regenxbio price target raised to $82 from $79 at Barclays
09/13/21 Chardan
Regenxbio pact with AbbVie accelerates RGX-314 'value capture,' says Chardan
09/08/21 JPMorgan
AbbVie offers 'best risk/reward story in the group,' says JPMorgan
09/07/21 Morgan Stanley
Morgan Stanley cuts Vertex Pharmaceuticals to Underweight amid AbbVie overhang
AYLA Ayala Pharmaceuticals
$12.26 /

-1.76 (-12.55%)

07/13/21 Ladenburg
Ayala Pharmaceuticals initiated with Buy, $29 target at Ladenburg
07/13/21 Ladenburg
Ayala Pharmaceuticals initiated with a Buy at Ladenburg
12/07/20
Fly Intel: Top five analyst initiations
12/07/20 Roth Capital
Ayala Pharmaceuticals initiated with a Buy at Roth Capital
DCPH Deciphera
$31.77 /

+0.72 (+2.32%)

08/04/21 H.C. Wainwright
Deciphera price target lowered to $70 from $75 at H.C. Wainwright
05/05/21 Barclays
Deciphera price target lowered to $65 from $70 at Barclays
05/05/21 H.C. Wainwright
Deciphera price target lowered to $75 from $80 at H.C. Wainwright
05/05/21 Piper Sandler
Deciphera price target lowered to $60 from $75 at Piper Sandler
GMAB Genmab
$42.26 /

-0.575 (-1.34%)

09/16/21
Fly Intel: Top five analyst downgrades
09/16/21 Jefferies
Genmab downgraded to Hold from Buy at Jefferies
09/07/21
Fly Intel: Top five analyst downgrades
09/07/21 Morgan Stanley
Morgan Stanley cuts Genmab to Underweight amid high investor expectations
LPTX Leap Therapeutics
$2.52 /

+0.57 (+29.23%)

09/16/21 Piper Sandler
Leap data show 'very favorable early signal,' says Piper Sandler
09/13/21 Raymond James
Leap Therapeutics price target raised to $4 from $3 at Raymond James
09/13/21 Piper Sandler
Leap combo sees 'strong' early response rate, says Piper Sandler
06/03/21 Baird
Leap Therapeutics transferred with Outperform at Baird
ORIC Oric Pharmaceuticals
$24.49 /

-0.31 (-1.25%)

07/06/21 Citi
Oric Pharmaceuticals upgraded to Buy after tumor data at Citi
07/06/21 Citi
Oric Pharmaceuticals upgraded to Buy from Neutral at Citi
03/25/21 H.C. Wainwright
Oric Pharmaceuticals price target raised to $54 from $52 at H.C. Wainwright
01/25/21 Citi
Oric Pharmaceuticals downgraded to Neutral from Buy at Citi
SYNH Syneos Health
$93.78 /

+0.07 (+0.07%)

08/04/21 Credit Suisse
Syneos Health assumed with an Outperform at Credit Suisse
07/13/21 Barclays
Syneos Health price target raised to $102 from $90 at Barclays
06/02/21 Truist
Syneos Health price target raised to $104 from $88 at Truist
04/30/21 Mizuho
Syneos Health price target raised to $90 from $82 at Mizuho
BGNE BeiGene
$385.26 /

+10.94 (+2.92%)

06/14/21 SVB Leerink
BeiGene price target raised to $417 from $388 at SVB Leerink
03/16/21 HSBC
BeiGene price target raised to $385 from $296 at HSBC
03/08/21 China Renaissance
BeiGene initiated with a Buy at China Renaissance
03/04/21 Goldman Sachs
Five Prime acquisition 'a strategic positive' for Amgen, says Goldman Sachs
BMY Bristol-Myers
$61.22 /

-0.78 (-1.26%)

09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
07/27/21 Mizuho
Bristol-Myers deal a positive signal about BridgeBio's BBP-398, says Mizuho
07/26/21 Truist
Bristol-Myers assumed with a Buy at Truist
07/26/21 Truist
Bristol-Myers assumed with a Buy at Truist
BYSI BeyondSpring
$22.50 /

-0.48 (-2.09%)

09/08/21 Baird
BeyondSpring initiated with an Outperform at Baird
08/04/21 Evercore ISI
BeyondSpring price target raised to $95 from $30 at Evercore ISI
08/04/21 William Blair
BeyondSpring may have new standard of care in lung cancer, says William Blair
08/04/21 H.C. Wainwright
Wainwright upgrades BeyondSpring with $100 target on lung cancer data
CALA Calithera Biosciences
$2.05 /

-0.04 (-1.91%)

01/05/21 SVB Leerink
Calithera Biosciences downgraded to Market Perform at SVB Leerink
01/05/21 SVB Leerink
Calithera Biosciences downgraded to Market Perform from Outperform at SVB Leerink
01/05/21 Citi
Calithera Biosciences price target lowered to $5 from $10 at Citi
01/05/21 H.C. Wainwright
Calithera Biosciences price target lowered to $4 from $9.50 at H.C. Wainwright
GILD Gilead
$71.32 /

-0.45 (-0.63%)

09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
07/30/21 BMO Capital
Gilead price target raised to $72 from $67 at BMO Capital
07/30/21 RBC Capital
Gilead price target raised to $84 from $81 at RBC Capital
06/29/21 Jefferies
Gilead data should move Yescarta up to second line in DLBCL, says Jefferies
GH Guardant Health
$127.00 /

-0.01 (-0.01%)

08/09/21 Canaccord
Guardant Health price target lowered to $180 from $195 at Canaccord
06/21/21 Wells Fargo
Guardant Health price target raised to $160 from $145 at Wells Fargo
06/15/21
Fly Intel: Top five analyst initiations
06/15/21 Raymond James
Guardant Health initiated with a Market Perform at Raymond James
LLY Eli Lilly
$230.95 /

-2.72 (-1.16%)

09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
09/02/21 SVB Leerink
AbbVie price target lowered to $142 from $148 at SVB Leerink
08/30/21 Cowen
Eli Lilly price target raised to $300 from $250 at Cowen
08/30/21 Citi
Lexicon price target raised to $20 from $13 at Citi
IPSEY Ipsen
$24.32 /

+0.23 (+0.95%)

08/16/21 Morgan Stanley
Ipsen price target lowered to EUR 88 from EUR 92 at Morgan Stanley
08/03/21 Morgan Stanley
Ipsen price target raised to EUR 92 from EUR 85 at Morgan Stanley
08/02/21 Societe Generale
Ipsen price target raised to EUR 101 from EUR 90 at Societe Generale
07/30/21 Credit Suisse
Ipsen price target raised to EUR 90 from EUR 75 at Credit Suisse
EXAS Exact Sciences
$102.81 /

-1.83 (-1.75%)

09/16/21 Canaccord
Exact Sciences salesforce expansion a net positive, says Canaccord
09/15/21 Raymond James
Exact Sciences' 'opportunistic' hires should boost sales, says Raymond James
09/15/21 Canaccord
Exact Sciences progress in MRD space a positive, says Canaccord
09/01/21 Baird
UnitedHealth update to CRC screening coverage not a surprise, says Baird
IDYA Ideaya Biosciences
$25.90 /

-0.1 (-0.38%)

06/03/21 Baird
Ideaya Biosciences assumed with an Outperform at Baird
04/22/21 Roth Capital
Ideaya Biosciences price target raised to $38 from $31 at Roth Capital
04/19/21 H.C. Wainwright
Ideaya Biosciences price target raised to $35 from $29 at H.C. Wainwright
04/16/21 Roth Capital
Ideaya Biosciences price target raised to $31 from $23 at Roth Capital
GSK GlaxoSmithKline
$39.10 /

-0.11 (-0.28%)

09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
08/26/21 UBS
GlaxoSmithKline price target raised to 1,540 GBp from 1,485 GBp at UBS
08/20/21 JPMorgan
GlaxoSmithKline price target raised to 1,500 GBp from 1,300 GBp at JPMorgan
08/19/21 Berenberg
GlaxoSmithKline price target raised to 1,625 GBp from 1,570 GBp at Berenberg
RHHBY Roche
$46.82 /

-0.04 (-0.09%)

09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
09/07/21 UBS
Roche price target raised to CHF 350 from CHF 345 at UBS
08/02/21 JPMorgan
Roche price target raised to CHF 360 from CHF 310 at JPMorgan
07/27/21 Societe Generale
Roche price target raised to CHF 353 from CHF 340 at Societe Generale
REGN Regeneron
$652.73 /

+2.13 (+0.33%)

09/15/21 Cantor Fitzgerald
Regeneron price target raised to $700 from $670 at Cantor Fitzgerald
09/15/21 H.C. Wainwright
Regeneron price target raised to $831 from $787 at H.C. Wainwright
09/15/21 Piper Sandler
Regeneron price target raised to $690 from $675 at Piper Sandler
09/09/21
Fly Intel: Top five analyst initiations
PFE Pfizer
$44.46 /

-0.31 (-0.69%)

09/16/21 Canaccord
Exact Sciences salesforce expansion a net positive, says Canaccord
09/16/21 BofA
Moderna boosters already reflected in 'bullish' consensus, says BofA
09/15/21 Raymond James
Exact Sciences' 'opportunistic' hires should boost sales, says Raymond James
09/13/21 JPMorgan
Pfizer price target raised to $42 from $40 at JPMorgan
TAK Takeda Pharmaceutical
$17.21 /

+0.205 (+1.21%)

08/03/21 Piper Sandler
Arcturus strength attributable to large pharma's interest in mRNA, says Piper
04/27/21 Chardan
LogicBio collaborations may signal recognition of platforms, says Chardan
04/19/21 JPMorgan
Takeda Pharmaceutical downgraded to Neutral on R&D investments at JPMorgan
04/19/21 JPMorgan
Takeda Pharmaceutical downgraded to Neutral from Overweight at JPMorgan
TMO Thermo Fisher
$560.75 /

-2.085 (-0.37%)

08/04/21 Credit Suisse
Thermo Fisher assumed with an Outperform at Credit Suisse
08/04/21 Argus
Thermo Fisher price target raised to $600 from $530 at Argus
07/29/21 Cowen
Thermo Fisher price target raised to $560 from $525 at Cowen
07/29/21 BTIG
Thermo Fisher price target raised to $610 from $590 at BTIG
TCRR TCR2 Therapeutics
$15.71 /

-0.51 (-3.14%)

08/06/21 BMO Capital
TCR2 Therapeutics price target lowered to $44 from $53 at BMO Capital
06/24/21 Goldman Sachs
TCR2 Therapeutics initiated with a Buy at Goldman Sachs
06/11/21 BMO Capital
TCR2 Therapeutics coverage transferred at BMO Capital
05/14/21 Wedbush
TCR2 Therapeutics price target lowered to $45 from $57 at Wedbush
VERU Veru
$8.76 /

-0.04 (-0.45%)

04/13/21 Jefferies
Veru initiated with a Buy at Jefferies
02/11/21 Oppenheimer
Veru price target raised to $24 from $19 at Oppenheimer
02/11/21 H.C. Wainwright
Veru price target raised to $22 from $17 at H.C. Wainwright
02/09/21 H.C. Wainwright
Veru price target raised to $17 from $12 at H.C. Wainwright
VBLT VBL Therapeutics
$2.35 /

+0.055 (+2.40%)

08/30/21 Roth Capital
Roth bullish on VBL Therapeutics as U.S. Phase 3 OVAL trial enrollment resumes
06/15/21 Roth Capital
Roth does not see material change to VBL readout timelines
06/03/21 Roth Capital
Roth Capital ups VBL Therapeutics target to $7 on OVAL primary endpoint update
05/18/21 Guggenheim
VBL Therapeutics initiated with a Buy at Guggenheim
VTRS Viatris
$13.70 /

-0.03 (-0.22%)

06/15/21 Citi
Viatris initiated with a Neutral at Citi
04/06/21 RBC Capital
Viatris transferred with an Outperform at RBC Capital
03/25/21 Piper Sandler
Piper says Biogen Tecfidera patents could change thesis, but sees unknowns
03/12/21 Piper Sandler
Viatris price target lowered to $16 from $17 at Piper Sandler
NVS Novartis
$84.37 /

-0.695 (-0.82%)

09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
09/07/21 Wedbush
Wedbush downgrades Xoma to Neutral, cuts target to $22
07/28/21 JPMorgan
Novartis price target raised to CHF 84 from CHF 80 at JPMorgan
07/27/21 Jefferies
Point Biopharma initiated with a Hold at Jefferies
ABBV AbbVie
$108.08 /

+0.29 (+0.27%)

AYLA Ayala Pharmaceuticals
$12.26 /

-1.76 (-12.55%)

DCPH Deciphera
$31.77 /

+0.72 (+2.32%)

LPTX Leap Therapeutics
$2.52 /

+0.57 (+29.23%)

ORIC Oric Pharmaceuticals
$24.49 /

-0.31 (-1.25%)

SYNH Syneos Health
$93.78 /

+0.07 (+0.07%)

BGNE BeiGene
$385.26 /

+10.94 (+2.92%)

BMY Bristol-Myers
$61.22 /

-0.78 (-1.26%)

BYSI BeyondSpring
$22.50 /

-0.48 (-2.09%)

CALA Calithera Biosciences
$2.05 /

-0.04 (-1.91%)

GILD Gilead
$71.32 /

-0.45 (-0.63%)

GH Guardant Health
$127.00 /

-0.01 (-0.01%)

LLY Eli Lilly
$230.95 /

-2.72 (-1.16%)

EXAS Exact Sciences
$102.81 /

-1.83 (-1.75%)

IDYA Ideaya Biosciences
$25.90 /

-0.1 (-0.38%)

GSK GlaxoSmithKline
$39.10 /

-0.11 (-0.28%)

RHHBY Roche
$46.82 /

-0.04 (-0.09%)

REGN Regeneron
$652.73 /

+2.13 (+0.33%)

PFE Pfizer
$44.46 /

-0.31 (-0.69%)

TAK Takeda Pharmaceutical
$17.21 /

+0.205 (+1.21%)

TMO Thermo Fisher
$560.75 /

-2.085 (-0.37%)

TCRR TCR2 Therapeutics
$15.71 /

-0.51 (-3.14%)

VERU Veru
$8.76 /

-0.04 (-0.45%)

VBLT VBL Therapeutics
$2.35 /

+0.055 (+2.40%)

VTRS Viatris
$13.70 /

-0.03 (-0.22%)

NVS Novartis
$84.37 /

-0.695 (-0.82%)

  • 08
    Jul
  • 03
    Jun
  • 04
    May
  • 09
    Apr
  • 01
    Mar
  • 18
    Feb
  • 20
    Jan
  • 02
    Dec
  • 02
    Dec
  • 19
    Nov
  • 13
    Nov
  • 07
    Oct
ABBV AbbVie
$108.08 /

+0.29 (+0.27%)

SYNH Syneos Health
$93.78 /

+0.07 (+0.07%)

BGNE BeiGene
$385.26 /

+10.94 (+2.92%)

BMY Bristol-Myers
$61.22 /

-0.78 (-1.26%)

GILD Gilead
$71.32 /

-0.45 (-0.63%)

LLY Eli Lilly
$230.95 /

-2.72 (-1.16%)

EXAS Exact Sciences
$102.81 /

-1.83 (-1.75%)

GSK GlaxoSmithKline
$39.10 /

-0.11 (-0.28%)

RHHBY Roche
$46.82 /

-0.04 (-0.09%)

REGN Regeneron
$652.73 /

+2.13 (+0.33%)

PFE Pfizer
$44.46 /

-0.31 (-0.69%)

TAK Takeda Pharmaceutical
$17.21 /

+0.205 (+1.21%)

TMO Thermo Fisher
$560.75 /

-2.085 (-0.37%)

NVS Novartis
$84.37 /

-0.695 (-0.82%)

ABBV AbbVie
$108.08 /

+0.29 (+0.27%)

GMAB Genmab
$42.26 /

-0.575 (-1.34%)

LPTX Leap Therapeutics
$2.52 /

+0.57 (+29.23%)

ORIC Oric Pharmaceuticals
$24.49 /

-0.31 (-1.25%)

BMY Bristol-Myers
$61.22 /

-0.78 (-1.26%)

BYSI BeyondSpring
$22.50 /

-0.48 (-2.09%)

GILD Gilead
$71.32 /

-0.45 (-0.63%)

GH Guardant Health
$127.00 /

-0.01 (-0.01%)

LLY Eli Lilly
$230.95 /

-2.72 (-1.16%)

EXAS Exact Sciences
$102.81 /

-1.83 (-1.75%)

IDYA Ideaya Biosciences
$25.90 /

-0.1 (-0.38%)

GSK GlaxoSmithKline
$39.10 /

-0.11 (-0.28%)

RHHBY Roche
$46.82 /

-0.04 (-0.09%)

REGN Regeneron
$652.73 /

+2.13 (+0.33%)

PFE Pfizer
$44.46 /

-0.31 (-0.69%)

TAK Takeda Pharmaceutical
$17.21 /

+0.205 (+1.21%)

TMO Thermo Fisher
$560.75 /

-2.085 (-0.37%)

VERU Veru
$8.76 /

-0.04 (-0.45%)

NVS Novartis
$84.37 /

-0.695 (-0.82%)

ABBV AbbVie
$108.08 /

+0.29 (+0.27%)

BMY Bristol-Myers
$61.22 /

-0.78 (-1.26%)

BYSI BeyondSpring
$22.50 /

-0.48 (-2.09%)

GILD Gilead
$71.32 /

-0.45 (-0.63%)

LLY Eli Lilly
$230.95 /

-2.72 (-1.16%)

GSK GlaxoSmithKline
$39.10 /

-0.11 (-0.28%)

REGN Regeneron
$652.73 /

+2.13 (+0.33%)

PFE Pfizer
$44.46 /

-0.31 (-0.69%)

TAK Takeda Pharmaceutical
$17.21 /

+0.205 (+1.21%)

VERU Veru
$8.76 /

-0.04 (-0.45%)

VTRS Viatris
$13.70 /

-0.03 (-0.22%)

Conference/Events
Morgan Stanley cross-asset strategists hold analyst/industry conference call » 04:55
09/17/21
09/17
04:55
09/17/21
04:55

Cross-Asset Strategists…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
Cars.com management to meet virtually with Truist » 04:55
09/17/21
09/17
04:55
09/17/21
04:55
CARS

Cars.com

$12.68 /

+0.02 (+0.16%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CARS Cars.com
$12.68 /

+0.02 (+0.16%)

08/27/21
Fly Intel: Top five analyst initiations
08/27/21 Truist
Cars.com initiated with a Buy at Truist on 'attractive' valuation
08/27/21 Truist
Cars.com initiated with a Buy at Truist
05/10/21 Barrington
Cars.com price target raised to $25 from $16 at Barrington
CARS Cars.com
$12.68 /

+0.02 (+0.16%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.